CAP GO Trademark

Trademark Overview


On Monday, July 11, 2016, a trademark application was filed for CAP GO with the United States Patent and Trademark Office. The USPTO has given the CAP GO trademark a serial number of 79197165. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 14, 2024. This trademark is owned by CEVEC Pharmaceuticals GmbH. The CAP GO trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Medicines for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except thyreostatics and cough and cold preparations; pharmaceutical and veterinary products, preparations and reagents for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, ...

Chemical, biological and biochemical products, preparations and reagents for scientific, research, laboratory, industrial and commercial purposes, except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for researching and characterizing diseases except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for scientific and medical research and drug development except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for manufacturing drugs and pharmaceuticals, except chromatography chemicals and media, and except chemicals for use in separation and purification; micro-organisms, proteins, polypeptides, nucleotides, nucleic acids, euk...

Scientific and industrial research, in particular in the fields of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures and expression systems; scientific, technical and industrial consultancy, in particular in the field of research medicine, pharmacy, molecular biology, biotechnology and genetics; scientific and industrial research and development of eukaryotic cell lines, eukaryotic cells, micro-organisms, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics, except services relating to capture and intermediate purification of proteins
cap go

General Information


Serial Number79197165
Word MarkCAP GO
Filing DateMonday, July 11, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 14, 2024
Registration Number5343212
Registration DateTuesday, November 28, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements


Certificate of Correction for RegistrationPage 2, In the statement, line 18, "genetics" should be deleted, and "genetics;" should be inserted.
Goods and ServicesMedicines for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except thyreostatics and cough and cold preparations; pharmaceutical and veterinary products, preparations and reagents for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, all afore mentioned goods except thyreostatics and cough and cold preparations; chemical, biological and biochemical preparations for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, preparations and reagents for medical and veterinary purposes for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except cough and cold preparations, except chromatography chemicals and media, and except chemicals for use in separation and purification; diagnostic and analytical preparations for medical and veterinary purposes for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases; cultures of micro-organisms, protein arrays, synthetic polypeptides, nucleotide arrays, nucleic acid sequence, eukaryotic cell lines and eukaryotic cells for medical, veterinary and diagnostic purposes, except cough and cold preparations
Goods and ServicesChemical, biological and biochemical products, preparations and reagents for scientific, research, laboratory, industrial and commercial purposes, except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for researching and characterizing diseases except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for scientific and medical research and drug development except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for manufacturing drugs and pharmaceuticals, except chromatography chemicals and media, and except chemicals for use in separation and purification; micro-organisms, proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells for scientific, research, laboratory, industrial and commercial purposes; all other than for medical or veterinary use
Goods and ServicesScientific and industrial research, in particular in the fields of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures and expression systems; scientific, technical and industrial consultancy, in particular in the field of research medicine, pharmacy, molecular biology, biotechnology and genetics; scientific and industrial research and development of eukaryotic cell lines, eukaryotic cells, micro-organisms, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics, except services relating to capture and intermediate purification of proteins

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 14, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCEVEC Pharmaceuticals GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameCEVEC Pharmaceuticals GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameCEVEC Pharmaceuticals GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Friday, December 2, 2016ASSIGNED TO EXAMINER
Thursday, December 1, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 6, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, December 7, 2016NON-FINAL ACTION WRITTEN
Thursday, December 8, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 8, 2016REFUSAL PROCESSED BY MPU
Thursday, December 8, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, December 24, 2016REFUSAL PROCESSED BY IB
Wednesday, June 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 27, 2018TEAS SECTION 7 REQUEST RECEIVED
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 27, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 28, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, March 7, 2018FINAL DISPOSITION PROCESSED
Wednesday, March 7, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 27, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 11, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 17, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 22, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 23, 2018POST REGISTRATION ACTION MAILED - SEC. 7
Friday, October 19, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, October 22, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, July 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 13, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 21, 2023TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, August 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 21, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, November 19, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 28, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, August 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 18, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 14, 2024CANCELLED SECTION 71